Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Increased Varenicline Dosing (1mg TID)
(D06282)
[1] Varenicline[2] Varenicline tartrate (D06282),
Varenicline 💬
[2] CHRNA4,
CHRNB2 💬
[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 298 💬
2Standard Varenicline Dosing (1 mg BID)
(D06282)
[1] Varenicline[2] Varenicline tartrate (D06282),
Varenicline 💬
[2] CHRNA4,
CHRNB2 💬
[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 298 💬
3Varenicline
(D06282)
[1] Varenicline[2] Varenicline tartrate (D06282),
Varenicline 💬
[2] CHRNA4,
CHRNB2 💬
[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[4] 6, 18, 53, 298 💬
4Varenicline Nasal Spray
(D06282)
[1] Varenicline[2] Varenicline tartrate (D06282),
Varenicline 💬
[2] CHRNA4,
CHRNB2 💬
[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 53 💬
5VARENICLINE TARTRATE
(D06282)
[1] Varenicline[2] Varenicline tartrate (D06282),
Varenicline 💬
[2] CHRNA4,
CHRNB2 💬
[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 6 💬